Massachusetts Financial Services Co. MA Has $28.07 Million Stock Position in UFP Technologies, Inc. (NASDAQ:UFPT)

Massachusetts Financial Services Co. MA decreased its stake in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 15.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 88,646 shares of the industrial products company's stock after selling 16,472 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.16% of UFP Technologies worth $28,074,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Congress Asset Management Co. lifted its holdings in shares of UFP Technologies by 0.4% in the third quarter. Congress Asset Management Co. now owns 246,303 shares of the industrial products company's stock valued at $78,004,000 after purchasing an additional 986 shares in the last quarter. Swedbank AB purchased a new stake in shares of UFP Technologies in the first quarter valued at $25,220,000. Mountain Pacific Investment Advisers LLC grew its holdings in shares of UFP Technologies by 0.3% during the third quarter. Mountain Pacific Investment Advisers LLC now owns 92,976 shares of the industrial products company's stock worth $29,445,000 after buying an additional 238 shares in the last quarter. Geneva Capital Management LLC boosted its position in UFP Technologies by 0.3% during the third quarter. Geneva Capital Management LLC now owns 80,362 shares of the industrial products company's stock worth $25,450,000 after acquiring an additional 243 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in UFP Technologies by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 52,877 shares of the industrial products company's stock valued at $13,953,000 after acquiring an additional 806 shares during the last quarter. 87.28% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO R Jeffrey Bailly sold 12,533 shares of UFP Technologies stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $346.46, for a total transaction of $4,342,183.18. Following the sale, the chief executive officer now owns 31,194 shares of the company's stock, valued at approximately $10,807,473.24. The trade was a 28.66 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Cynthia L. Feldmann sold 647 shares of UFP Technologies stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $352.30, for a total transaction of $227,938.10. Following the sale, the director now owns 4,049 shares in the company, valued at approximately $1,426,462.70. This represents a 13.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,326 shares of company stock valued at $4,620,154. Company insiders own 6.17% of the company's stock.

UFP Technologies Trading Down 1.1 %

Shares of UFPT stock traded down $3.46 during mid-day trading on Tuesday, hitting $310.95. 33,935 shares of the company's stock were exchanged, compared to its average volume of 61,420. The stock has a market cap of $2.39 billion, a price-to-earnings ratio of 44.85 and a beta of 0.96. The stock has a 50-day simple moving average of $308.34 and a two-hundred day simple moving average of $298.25. UFP Technologies, Inc. has a fifty-two week low of $152.43 and a fifty-two week high of $366.41. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.